Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Alexza Pharmaceuticals Inc. | alxa-ex311_8.htm |
| EX-21.1 - EX-21.1 - Alexza Pharmaceuticals Inc. | alxa-ex211_6.htm |
| EX-32.1 - EX-32.1 - Alexza Pharmaceuticals Inc. | alxa-ex321_9.htm |
| EX-23.2 - EX-23.2 - Alexza Pharmaceuticals Inc. | alxa-ex232_527.htm |
| EX-31.2 - EX-31.2 - Alexza Pharmaceuticals Inc. | alxa-ex312_605.htm |
| 10-K - 10-K - Alexza Pharmaceuticals Inc. | alxa-10k_20151231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements and related prospectuses:
|
|
1. |
Registration Statements on Forms S-8 (Nos. 333-132593, 333-141718, 333-149129, 333-151303, 333-162485, 333-164843, 333-171604, 333-176173, 333-180048, 333-186249, 333-189011, 333-194803 and 333-202760) pertaining to the 2005 Equity Incentive Plan, 2005 Non-Employee Directors’ Stock Option Plan and 2005 Employee Stock Purchase Plan of Alexza Pharmaceuticals, Inc. and (Nos. 333-205860 and 333-207585) pertaining to the 2015 Equity Incentive Plan, 2015 Non-Employee Directors’ Stock Option Plan and 2015 Employee Stock Purchase Plan of Alexza Pharmaceuticals, Inc., and |
|
|
2. |
Registration Statements on Forms S-3 (Nos. 333-161804, 333-162582, 333-166514, 333-169649 and 333-182341) of Alexza Pharmaceuticals, Inc.; |
of our report dated March 28, 2016, with respect to the consolidated financial statements of Alexza Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the fiscal year ended December 31, 2015.
/s/ OUM & CO. LLP
San Francisco, California
March 28, 2016